Akcje

Kapitalizacja (USD)	4 900 161 216
Aktywa:	4 131 508 000
Cena:	86.96
Wskaźnik Altman Z-Score:	3.4 Stabilny (niskie ryzyko bankructwa)
Dywidenda:	1
P/E:	16.2
Ilość akcji w obrocie:	99%
Średni wolumen:	496 811
Ilość akcji	56 349 600

Przychody TTM	5 306 197 000
Zobowiązania:	2 288 693 000
Przedział 52 tyg.:	63.77 - 93.94
Piotroski F-Score:	8 Silny (dobra jakość finansowa)
EPS:	5.4
P/E branży:	19.3
Beta:	0.768
Raport okresowy:	2025-11-19
WWW:	https://www.maximus.com

Imie i Nazwisko	Stanowisko	Wynagrodzenie	Rok urodzenia
Mr. David W. Mutryn	Chief Financial Officer & Treasurer	861 270	1982
Ms. Ilene R. Baylinson	General Manager of Health Services U.S.	851 264	1958
Mr. Bruce L. Caswell	President, Chief Executive Officer & Director	1 761 189	1967
Ms. Elisabeth Schmidt	Senior Vice President of Technology & Consulting Services	0	0
Ms. Julia Bailey	Senior Vice President of Global Ethics & Compliance	0	0
Ms. Theresa D. Golinvaux	Principal Accounting Officer, Senior Vice President & Corporate Controller	0	1975
Mr. Derrick Pledger	Chief Digital & Information Officer (CDIO)	0	0
Mr. John T. Martinez	General Counsel, Chief Legal Officer & Corporate Secretary	0	1973
Mr. Jericho Seguin	Senior Vice President of Corporate Development & Strategic Planning	0	0
Ms. Eileen Cassidy Rivera	Vice President of Communications & Public Relations	0	0

Symbol ETF	Ilość akcji	Wartość
IJH	1 774 519	131 065 977
VB	1 377 282	96 685 196
IWM	1 311 112	96 838 752
VBR	878 545	61 673 859
FVD	549 876	39 393 116
IWO	479 731	35 432 936
MDY	431 637	30 747 834
IJJ	302 496	22 342 357
VTWO	287 943	20 213 598
SCHA	266 116	18 758 567
SPMD	258 743	18 548 357
VYM	217 131	15 242 596
DFAT	189 428	13 991 152
DFAS	159 900	11 810 214
SCHM	149 432	10 527 937
XMLV	136 259	9 705 728
FNDA	130 723	9 196 228
DES	122 395	9 040 094
FESM	108 730	7 923 155
DFAC	108 128	7 986 334
QVAL	107 683	7 930 000
MDYV	96 170	6 933 938
R2SC.L	85 653	4 623 324
R2US.L	85 653	6 101 063
ZPRR.DE	85 653	5 342 700
IVOO	82 907	5 820 071
SPY4.L	76 202	5 427 868
SPY4.DE	76 202	4 753 184
2B78.DE	66 715	4 310 619
DRDR.L	66 715	3 729 563
HEAL.L	66 715	4 927 548
ITOT	63 873	4 717 634
VIS	60 260	4 230 252
VTWG	50 189	3 523 267
DFUV	48 613	3 590 556
FNX	47 020	3 368 512
PSC	44 172	3 262 543
IUSV	43 419	3 206 917
IVOV	42 107	2 955 911
XMUD.L	38 730	2 860 596
XMUS.L	38 730	216 773 164
DBXU.DE	38 730	2 505 024
SMMV	36 484	2 598 755
SCHB	32 661	2 317 681
XRS2.DE	32 558	2 105 817
XRSU.L	32 558	2 404 724
XRSG.L	32 558	182 227 640
FSMD	30 401	2 215 320
RSSL	28 909	2 135 218
FELV	26 378	1 922 164
BBMC	26 372	1 947 835
SFLO	26 216	1 936 313
RWK	26 004	1 852 264
FNDX	25 620	1 814 278
RFV	20 435	1 455 585
EZM	19 009	1 404 004
FNK	16 794	1 203 122
PRF	15 974	1 137 828
JPSE	15 954	1 178 362
VFQY	15 705	1 102 491
ESML	14 804	1 054 488
FIDU	13 989	1 019 378
IWV	13 623	1 006 194
SMLF	13 551	1 000 852
SMLV	13 333	960 210
FDLS	12 760	942 453
ESGV	12 360	867 672
SPTM	11 683	833 512
DFAU	11 619	858 179
XSU.TO	9 778	961 886
GSSC	9 237	664 325
TILT	9 060	669 171
ISCG	8 681	641 212
ZPRV.DE	8 136	442 066
USSC.L	8 136	504 814
PTMC	8 003	591 101
DFSU	7 928	585 562
VFVA	7 891	553 948
QVMM	7 709	549 112
XMC.TO	7 408	728 679
KONG	6 995	0
XJH	6 133	436 853
DCOR	6 092	449 955
IJH.AX	5 737	632 537
UWM	5 732	423 365
ISMD	5 694	420 558
CUS1.L	5 665	316 682
CSUSS.MI	5 665	366 020
CUSS.L	5 665	418 405
SXRG.DE	5 665	366 020
PDN	5 143	59 313
XMH.TO	4 924	484 347
URTY	4 745	350 465
BTAL	4 640	405 327
SCHK	4 346	308 472
VTHR	4 236	297 367
DTD	3 753	277 196
OMFS	3 686	262 553
AFMC	3 621	259 408
VALQ	3 497	296 339
DIVB	3 194	227 508
FAB	2 989	214 131
XUU.TO	2 546	250 489
ISCB	2 496	184 343
FDHT	2 386	173 867
IYY	2 261	167 034
MVV	2 220	163 969
VVL.TO	2 165	207 380
FNDB	2 143	151 635
DFSV	2 058	152 003
ROUS	1 919	136 690
GUSA	1 892	136 072
HSMV	1 823	130 599
STXK	1 804	133 243
DXUV	1 664	122 903
VFMF	1 529	107 335
MMSC	1 368	98 003
VLU	1 274	91 256
MFUS	1 174	83 624
MIDU	982	72 530
CSA	930	63 398
V3AL.L	772	54 194
V3AB.L	772	41 067
V3AA.L	772	54 194
AFSM	538	38 542
XBAL.TO	382	37 614
XUH.TO	376	26 775
BUYO	350	25 851
UMDD	343	25 333
EBIT	334	23 790
CSF	289	19 701
CBUG.DE	267	17 260
EWSA.AS	267	19 730
GVLU	265	0
USUE.DE	238	16 961
USFM.L	238	16 961
STXV	230	16 987
MIDE	149	10 613
IETC	134	9 544
HDG	68	5 022
SPDG	26	1 864
MMTM	22	1 563
SAGP	16	0
XTR.TO	15	1 083
RTYS.L	0	397 055
IGDA.L	0	84 163
PSRW.L	0	2 403 320
PSRF.L	0	7 567 158
6PSA.DE	0	87 288
PLV.TO	0	7 204
PSWD.DE	0	27 722
SC0K.DE	0	347 900
PXS.TO	0	5 120
PRUS.L	0	99 621

Wiadomości dla Maximus, Inc.

Tytuł	Treść	Źródło	Aktualizacja	Link
Should Value Investors Buy Maximus (MMS) Stock?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2025-05-16 14:45:44	Czytaj oryginał (ang.)
Best Income Stocks to Buy for May 12th	SUZ, ADRNY and MMS made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 12, 2025.	zacks.com	2025-05-12 15:36:04	Czytaj oryginał (ang.)
Maximus, Inc. (MMS) Q2 2025 Earnings Call Transcript	Maximus, Inc. (NYSE:MMS ) Q2 2025 Results Conference Call May 8, 2025 9:00 AM ET Company Participants Jessica Batt - Vice President of Investor Relations and ESG Bruce Caswell - President and Chief Executive Officer David Mutryn - Chief Financial Officer and Treasurer Conference Call Participants Charles Strauzer - CJS Securities Operator Greetings, and welcome to the Maximus Fiscal 2025 Second Quarter Conference Call. At this time, all participants are in a listen-only mode.	seekingalpha.com	2025-05-10 13:46:04	Czytaj oryginał (ang.)
Maximus' Q2 Earnings & Revenues Beat Estimates, Increase Y/Y	MMS' second-quarter fiscal 2025 earnings and revenues increased year over year.	zacks.com	2025-05-09 16:50:36	Czytaj oryginał (ang.)
Maximus (MMS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates	Although the revenue and EPS for Maximus (MMS) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.	zacks.com	2025-05-08 14:35:57	Czytaj oryginał (ang.)
Maximus (MMS) Q2 Earnings and Revenues Surpass Estimates	Maximus (MMS) came out with quarterly earnings of $2.01 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.57 per share a year ago.	zacks.com	2025-05-08 12:50:42	Czytaj oryginał (ang.)
Maximus Reports Fiscal Year 2025 Second Quarter Results	TYSONS, Va.--(BUSINESS WIRE)--Maximus reports financial results for the three and six months ending March 31, 2025.	businesswire.com	2025-05-08 10:30:00	Czytaj oryginał (ang.)
Gear Up for Maximus (MMS) Q2 Earnings: Wall Street Estimates for Key Metrics	Evaluate the expected performance of Maximus (MMS) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.	zacks.com	2025-05-07 14:21:32	Czytaj oryginał (ang.)
MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)	Propensity Score-Matched, Comparative Cost-Effectiveness Analysis of the Company's EPIFIX® Placental Allograft Product Propensity Score-Matched, Comparative Cost-Effectiveness Analysis of the Company's EPIFIX® Placental Allograft Product	globenewswire.com	2025-05-05 12:30:00	Czytaj oryginał (ang.)
Are Investors Undervaluing Maximus (MMS) Right Now?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2025-04-24 14:45:47	Czytaj oryginał (ang.)
Here's Why You Should Add Maximus Stock to Your Portfolio Now	MMS maintains solid relationships and a strong reputation with governments.	zacks.com	2025-04-11 16:20:37	Czytaj oryginał (ang.)
Maximus (MMS) Upgraded to Strong Buy: What Does It Mean for the Stock?	Maximus (MMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).	zacks.com	2025-04-10 17:01:14	Czytaj oryginał (ang.)
Maximus Schedules Fiscal 2025 Second Quarter Conference Call	TYSONS, Va.--(BUSINESS WIRE)--Maximus schedules its second quarter earnings call for FY25 for Thursday, May 8, and will issue a release with its financial results that morning.	businesswire.com	2025-04-10 13:00:00	Czytaj oryginał (ang.)
Buy the Dip in These Highly Ranked Stocks Near 52-Week Lows: MMS, RNG	Government program operator Maximus (MMS) and internet software services provider RingCentral (RNG) are two stocks that have become increasingly intriguing near their 52-week lows.	zacks.com	2025-04-08 18:55:29	Czytaj oryginał (ang.)
Maximus Benefits From Buyouts & Strong Cash Flow From Operations	The MMS stock is improving on the back of a strong operating cash flow, providing it with a competitive edge.	zacks.com	2025-04-03 16:40:51	Czytaj oryginał (ang.)
Is Maximus (MMS) Stock Undervalued Right Now?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2025-03-31 14:41:17	Czytaj oryginał (ang.)
Maximus Total Experience Management (TXM) Adds Salesforce's Agentforce to Transform Customer Experience for Government	TYSONS, Va.--(BUSINESS WIRE)--Maximus announces new technology partnership with Salesforce.	businesswire.com	2025-03-24 13:00:00	Czytaj oryginał (ang.)
Should Value Investors Buy Maximus (MMS) Stock?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2025-03-13 12:46:14	Czytaj oryginał (ang.)
Here's Why You Should Add Maximus Stock to Your Portfolio Now	MMS maintains solid relationships and a strong reputation with governments.	zacks.com	2025-03-10 15:35:18	Czytaj oryginał (ang.)
Maximus (MMS) Upgraded to Strong Buy: Here's Why	Maximus (MMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).	zacks.com	2025-03-04 15:05:34	Czytaj oryginał (ang.)
Are Investors Undervaluing Maximus (MMS) Right Now?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2025-02-25 12:40:35	Czytaj oryginał (ang.)
Maximus' Q1 Earnings & Revenues Beat Estimates, Increase Y/Y	MMS' first-quarter fiscal 2025 revenues and earnings rise 20.2% and 5.7% on a year-over-year basis.	zacks.com	2025-02-14 11:26:17	Czytaj oryginał (ang.)
Maximus, Inc. (MMS) Q1 2025 Earnings Call Transcript	Maximus, Inc. (NYSE:MMS ) Q1 2025 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Jessica Batt - Vice President of Investor Relations and ESG Bruce Caswell - President and Chief Executive Officer David Mutryn - Chief Financial Officer and Treasurer Conference Call Participants Charlie Strauzer - CJS Securities Brian Gesuale - Raymond James Operator Greetings and welcome to the Maximus Fiscal 2025 First Quarter Conference Call. At this time, all participants are in a listen-only mode.	seekingalpha.com	2025-02-06 15:02:20	Czytaj oryginał (ang.)
Maximus (MMS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates	While the top- and bottom-line numbers for Maximus (MMS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.	zacks.com	2025-02-06 12:36:24	Czytaj oryginał (ang.)
Maximus (MMS) Q1 Earnings and Revenues Top Estimates	Maximus (MMS) came out with quarterly earnings of $1.61 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.34 per share a year ago.	zacks.com	2025-02-06 10:41:12	Czytaj oryginał (ang.)
Maximus Reports Fiscal Year 2025 First Quarter Results	TYSONS, Va.--(BUSINESS WIRE)--Maximus reports financial results for the three months ending December 31, 2024.	businesswire.com	2025-02-06 08:30:00	Czytaj oryginał (ang.)
Should Value Investors Buy Maximus (MMS) Stock?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2025-02-04 12:45:42	Czytaj oryginał (ang.)
Should Value Investors Buy Maximus (MMS) Stock?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2025-01-16 12:45:27	Czytaj oryginał (ang.)
Best Value Stocks to Buy for January 13th	GBX, FHN and MMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 13, 2025.	zacks.com	2025-01-13 13:50:20	Czytaj oryginał (ang.)
Maximus Schedules Fiscal 2025 First Quarter Conference Call	TYSONS, Va.--(BUSINESS WIRE)--Maximus schedules its first quarter earnings call for FY25 for Thursday, February 6, and will issue a release with its financial results that morning.	businesswire.com	2025-01-09 11:00:00	Czytaj oryginał (ang.)
Here's Why You Should Add Maximus Stock to Your Portfolio Now	MMS maintains solid relationships and a strong reputation with governments.	zacks.com	2025-01-07 16:31:33	Czytaj oryginał (ang.)
Maximus Wins Contracts to Continue Medical Disability Exam Services for Veterans	TYSONS, Va.--(BUSINESS WIRE)--Maximus (NYSE: MMS), a leading employer and provider of government services, today announced that VES, a Maximus Company, was re-awarded contracts for domestic Regions 1 through 4, collectively spanning the continental U.S., to continue providing Medical Disability Exam (MDE) services on behalf of the VBA. The cumulative value of the award to VES more than accommodates current and anticipated production volumes over the contract term and each of the four regional c.	businesswire.com	2025-01-06 10:00:00	Czytaj oryginał (ang.)
Maximus Declares Quarterly Cash Dividend of $0.30 Per Share	TYSONS, Va.--(BUSINESS WIRE)--Maximus announces a quarterly cash dividend of $0.30 per share, payable on February 28, 2025, to shareholders of record on February 15, 2025.	businesswire.com	2025-01-06 08:30:00	Czytaj oryginał (ang.)
Are Investors Undervaluing Maximus (MMS) Right Now?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2024-12-31 13:01:32	Czytaj oryginał (ang.)
Is Maximus (MMS) Stock Undervalued Right Now?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2024-12-12 12:41:11	Czytaj oryginał (ang.)
Maximus (MMS) Loses -21.83% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner	Maximus (MMS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.	zacks.com	2024-12-11 12:35:54	Czytaj oryginał (ang.)
Maximus Completes Divestiture of Australia and South Korea in Outside the U.S. Segment	TYSONS, Va.--(BUSINESS WIRE)--Maximus divests all operations in Australia and South Korea, which were reported under the Outside the U.S. segment, to Angus Knight.	businesswire.com	2024-12-10 10:00:00	Czytaj oryginał (ang.)
Here's Why Maximus Stock is a Great Pick for You Right Now	MMS stock is benefiting from business process expansion on the back of strategic buyouts. Consistent dividend payments boost investor confidence.	zacks.com	2024-12-06 12:41:29	Czytaj oryginał (ang.)
Maximus Earns URAC Accreditation for Health Utilization Management in Clinical Reviews	TYSONS, Va.--(BUSINESS WIRE)--Maximus has again earned URAC full accreditation for Health Utilization Management for clinical reviews.	businesswire.com	2024-12-04 12:00:00	Czytaj oryginał (ang.)
Should Value Investors Buy Maximus (MMS) Stock?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2024-11-26 12:40:57	Czytaj oryginał (ang.)
Down -16.15% in 4 Weeks, Here's Why Maximus (MMS) Looks Ripe for a Turnaround	Maximus (MMS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.	zacks.com	2024-11-25 12:35:14	Czytaj oryginał (ang.)
Maximus, Inc. (MMS) Q4 2024 Earnings Call Transcript	Maximus, Inc. (NYSE:MMS ) Q4 2024 Earnings Call Transcript November 21, 2024 9:00 AM ET Company Participants Jessica Batt - VP of IR and ESG Bruce Caswell - President and CEO David Mutryn - CFO Conference Call Participants Charlie Strauzer - CJS Securities Operator Greetings, and welcome to the Maximus Fiscal 2024 Fourth Quarter and Year End Earnings Conference Call. At this time, all participants are on a listen-only mode.	seekingalpha.com	2024-11-21 18:12:44	Czytaj oryginał (ang.)
Maximus' Q4 Revenues Surpass Estimates, Earnings Miss	Maximus' fourth-quarter fiscal 2024 earnings and revenues increase on a year-over-year basis.	zacks.com	2024-11-21 11:30:34	Czytaj oryginał (ang.)
Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session	U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Thursday.	benzinga.com	2024-11-21 09:28:31	Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Maximus (MMS) Q4 Earnings	The headline numbers for Maximus (MMS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.	zacks.com	2024-11-20 21:00:30	Czytaj oryginał (ang.)
Maximus (MMS) Lags Q4 Earnings Estimates	Maximus (MMS) came out with quarterly earnings of $1.46 per share, missing the Zacks Consensus Estimate of $1.47 per share. This compares to earnings of $1.29 per share a year ago.	zacks.com	2024-11-20 20:16:37	Czytaj oryginał (ang.)
Maximus Reports Fourth Quarter and Full Year Results for Fiscal Year 2024	TYSONS, Va.--(BUSINESS WIRE)--Maximus announces its fourth quarter and year-end results for fiscal year 2024.	businesswire.com	2024-11-20 18:05:00	Czytaj oryginał (ang.)
Curious about Maximus (MMS) Q4 Performance? Explore Wall Street Estimates for Key Metrics	Get a deeper insight into the potential performance of Maximus (MMS) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.	zacks.com	2024-11-15 12:21:31	Czytaj oryginał (ang.)
Best Value Stocks to Buy for October 17th	NEXN, HRB and MMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 17, 2024.	zacks.com	2024-10-17 11:05:26	Czytaj oryginał (ang.)
Are Investors Undervaluing Maximus (MMS) Right Now?	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.	zacks.com	2024-10-15 14:45:50	Czytaj oryginał (ang.)
New Strong Buy Stocks for October 11th	AGESY, INTA, STEP, CURV and MMS have been added to the Zacks Rank #1 (Strong Buy) List on October 11, 2024.	zacks.com	2024-10-11 08:16:09	Czytaj oryginał (ang.)
Maximus Stock Ascends 11% in Six Months: Buy, Hold or Sell?	MMS exhibits strong long-term growth potential, making it a stock worth monitoring for an ideal investment opportunity.	zacks.com	2024-09-26 16:25:19	Czytaj oryginał (ang.)
Efficient Receivables Management Aids Maximus Amid Declining Income	Expertise in business process management and the ability to deliver efficient and cost-effective solutions make MMS a lucrative choice for governments.	zacks.com	2024-09-18 13:56:21	Czytaj oryginał (ang.)

Sektor:	Przemysł
Branża:	Specialty Business Services
Zatrudnienie:	39 600
Giełda:	Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie:	98.9796
Ilość akcji:	Brak danych
Debiut giełdowy:	1997-06-13
WWW:	https://www.maximus.com
CEO:	Mr. Bruce L. Caswell
Adres:	1600 Tysons Boulevard
Siedziba:	22102 Tysons
ISIN:	US5779331041

Notowania:

Opis firmy:

Informacje o spółce:

Wskaźniki finansowe

Wskaźniki finansowe

Zarząd

Lista ETF z ekspozycją na akcje Maximus, Inc.

Wiadomości dla Maximus, Inc.